In liver cancer models, TRIB2 overexpression conversely stabilizes the co-activator YAP, an oncogenic transcription factor, via binding to the distinct E3 ubiquitin ligase β-TRCP 57, 58. The gene discussed is TRIB2; the disease is liver cancer.